We are live on ! Find out more
PKBOW

Peak Bio, Inc. Warrant
PKBOW

Delisted

PKBOW was delisted on the 5th of January, 2023.

16 hedge funds and large institutions have $948K invested in Peak Bio, Inc. Warrant in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

7% more funds holding

Funds holding: 1516 (+1)

40% less capital invested

Capital invested by funds: $1.59M → $948K (-$645K)

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
16
Holders Change
+1
Holders Change %
+6.67%
% of All Funds
0.25%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
4
Closed
1
Calls
Puts
Net Calls
Net Calls Change

PKBOW Hedge Fund Activity: Q1 2022 in Review

16 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in Peak Bio, Inc. Warrant (PKBOW) for Q1 2022, worth a combined $948K — down 40% from $1.59M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new PKBOW positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 4 trimmed.

The largest buyer was Shaolin Capital Management, opening a new position worth an estimated $19.3K. The largest seller was Integrity Capital Management (HK), cutting an estimated $12.7K.

  • 16 institutional investors held Peak Bio, Inc. Warrant (PKBOW) as of Q1 2022, up from 15 in Q4 2021.
  • Funds reported $948K of Peak Bio, Inc. Warrant stock for Q1 2022, down 40% quarter-over-quarter.
  • 2 funds opened new Peak Bio, Inc. Warrant positions in Q1 2022 and 1 closed out, a net change of +1 holder.
  • The largest Peak Bio, Inc. Warrant buyer in Q1 2022 was Shaolin Capital Management, an estimated $19.3K added.
  • The largest Peak Bio, Inc. Warrant seller in Q1 2022 was Integrity Capital Management (HK), an estimated $12.7K sold.

Based on aggregated 13F filings for Q1 2022.